Cancer numbers are rising globally, partially due to the increasing age in industrial countries, and partially because of the growing world’s population. More and more frequently, cancer is evolving into a chronic condition, forcing patients to take high-class drugs over the long term.
Targeted drugs compliment standard therapy
In cancer therapy, the classic triad of medical treatment, radiation therapy and surgery is a proven and successful procedure for most cases. While radiation therapy uses ionizing radiation to inactivate the tumor, cytostatic drugs are applied in chemotherapy to purposefully inhibit cell growth. In the industrial world, the standard regimen is additionally combined with targeted medicines, whereas in emerging countries the focus is on chemotherapy with generic medication.
Infusion is the most common dosage form in cancer treatment. We manufacture sterile filling lines, which are often combined with barrier systems for processing highly potent drugs. This offers maximum operator protection during the manufacturing process while ensuring the best possible quality of the medicine. Some cytostatic drugs are also administered orally as tablets and capsules. These can be processed on our capsule filling machines and tablet presses. Source materials and aggregates are mixed, granulated and coated on equipment provided by Hüttlin. While industrial countries have an increasing demand for high-quality equipment designed to enable small batch production, the emerging markets require robust equipment with medium output. By carefully analyzing the exact needs of patients and pharmacists at an early development stage, our equipment portfolio offers suitable machines and lines for all requirements. So far Bosch has sold 17 machines with barrier systems, which, when added up, can fill up to 150,000 units per hour for cancer therapies.
Dr. Johannes Rauschnabel
Chief Pharma Expert
phone: +49 (0) 7951 402 452